NYSE: ELEstee Lauder Companies Inc Stock
$78.17-1.12 (-1.41%)
Updated Dec 5, 2024
EL Price
$78.17
Fair Value Price
N/A
Market Cap
$28.06B
52 Week Low
$62.29
52 Week High
$159.75
P/E
137.14x
P/B
5.52x
P/S
2.32x
PEG
1.67x
Dividend Yield
2.14%
Revenue
$15.45B
Earnings
$203.00M
Gross Margin
72.3%
Operating Margin
5.87%
Profit Margin
1.3%
Debt to Equity
3.19
Operating Cash Flow
$2B
Beta
1.09
Next Earnings
Feb 4, 2025
Ex-Dividend
Nov 29, 2024
Next Dividend
Dec 16, 2024
EL Overview
Estée Lauder Companies Inc. is a multinational cosmetics company. It manufactures and markets makeup, skincare, fragrance, and hair care products. The company's brands include Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, and Origins. The company was founded in 1946 is based in New York, NY.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine EL's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Value
D
Growth
F
Momentum
C
Sentiment
B
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Household & Personal Product
Industry Rating
B
EL
Ranked#24 of 25
Ranked#24 of 25
Be the first to know about important EL news, forecast changes, insider trades & much more!
EL News
Overview
Due Diligence Score
–
Industry Average (37)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how EL scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
EL ($78.17) is trading above its intrinsic value of $19.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
EL is poor value based on its earnings relative to its share price (137.14x), compared to the US market average (29.14x)
P/E vs Market Valuation
EL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more EL due diligence checks available for Premium users.
Valuation
EL price to earnings (PE)
For valuing profitable companies with steady earnings
Company
137.14x
Industry
32.93x
Market
29.14x
EL is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
EL is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
EL price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.52x
Industry
7.58x
EL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
EL price to earnings growth (PEG)
For valuing profitable companies with growth potential
EL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
EL's financial health
Profit margin
Revenue
$3.4B
Net Income
-$156.0M
Profit Margin
-4.6%
EL's Earnings (EBIT) of $907.00M... subscribe to Premium to read more.
Interest Coverage Financials
EL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$21.3B
Liabilities
$16.2B
Debt to equity
3.19
EL's short-term assets ($7.22B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EL's long-term liabilities ($10.75B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
EL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$670.0M
Investing
-$160.0M
Financing
-$226.0M
EL's operating cash flow ($2.10B)... subscribe to Premium to read more.
Debt Coverage Financials
EL vs Household & Personal Product Stocks
Estee Lauder Companies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.